Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

3-year Follow-up Study in Patients Previously Treated With a TMC435 for the Treatment of Hepatitis C Virus (HCV) Infection

This study has been completed.
Information provided by (Responsible Party):
Janssen R&D Ireland Identifier:
First received: April 26, 2011
Last updated: January 19, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)